Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597532 · ClinicalTrials.gov registry record · NA
Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled Study
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT00597532: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00597532 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00597532, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
To Test Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue using a Randomized Placebo Controlled Study. Objectives: * To determine (by immunohistochemistry) whether specific cellular markers and gene products associated with breast carcinoma can be altered by soy therapy. * To identify genes that can be altered by soy therapy in normal and neoplastic breast tissues by unbiased gene expression analysis using microarrays. * To compare specific cellular markers and pathways (immunohistochemistry), and gene expression using microarrays in normal and cancerous breast tissue.
Interventions
- DIETARY_SUPPLEMENT Soy
- DIETARY_SUPPLEMENT Milk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2002-08 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00597532
The ClinicalTrials.gov registry entry for NCT00597532 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Soy is the first listed.
NCT00597532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00597532 about?
NCT00597532 is a clinical study titled "Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled Study". To Test Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue using a Randomized Placebo Controlled Study. Objectives: * To determine (by immunohistochemistry) whether specific cellular markers and gene products associated with breast carcinoma can be altered by s...
What is the current status of trial NCT00597532?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2002-08. Estimated completion is 2016-04.
What interventions are being tested in trial NCT00597532?
The interventions under investigation include: Soy (DIETARY_SUPPLEMENT), Milk (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00597532?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.